semaglutide / pyridoxine hcl FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products DietWorks GLP FDA issues warning about some – Weight Loss & Metabolic Peptides

Produced in FDA-registered, GMP-certified facilities

Parenteral administration of vitamin B12 effectively and promptly replenishes B12 stores

Consider the penalties for violating the FD&C Act: When preparing drug compounds in compliance with Section 503A of the Food, Drug, and Cosmetic Act (FD&C Act), drug compounding pharmacies are exempt from certain FDA laws regarding good manufacturing practices, labeling requirements, and new drug approval applications

The FDA began allowing the distribution of compounded semaglutide and tirzepatide when both drugs were initially placed on the agencys drug shortage list in 2022